Latest News

National Health Investors, Inc. recently reported its second quarter 2025 results, showing increases in revenue and net income compared to the previous year, alongside an announced quarterly dividend of US$0.92 per share payable on October 31, 2025. Although sales and revenue advanced year over year, basic and diluted earnings per share from continuing operations slightly declined for the quarter, highlighting a shift in earnings allocation or cost structure. We'll take a closer look at how...

Sandstorm Gold Ltd. recently reported strong second quarter and first-half 2025 results, with sales and net income climbing to US$30.28 million and US$15.46 million respectively for the quarter, alongside reaffirmed production guidance for the year. Despite a decrease in attributable gold equivalent ounces produced in the quarter compared to the prior year, both earnings and revenue showed robust growth, signaling solid operational momentum and continued investor confidence. We'll explore...

ReNew Energy Global Plc recently reported its first quarter FY26 results, recording INR41.18 billion in revenue and a net profit of INR5.13 billion, both showing significant year-over-year increases. The company's clean power capacity grew by 23% and ReNew surpassed analyst revenue estimates, while also reiterating guidance for continued capacity and operational expansion. We’ll explore how ReNew’s robust profit jump and clean energy capacity growth may shape the company’s longer-term...

National HealthCare Corporation recently reported its second quarter and six-month 2025 financial results, highlighting year-over-year revenue growth and confirming a quarterly dividend of US$0.64 per share for shareholders of record on September 30, 2025, payable on October 31, 2025. The combination of higher revenue and the continuation of regular dividend payments underscores the company’s commitment to returning value to shareholders despite a lower quarterly net income. We'll explore...

Constellation Software reported its second quarter and half-year 2025 results, showing revenue growth to US$2.84 billion and US$5.50 billion, respectively, but with a sharp drop in net income compared to the prior year. Despite higher sales and the continuation of its US$1.00 per share quarterly dividend, profitability pressures emerged, as net income and earnings per share both declined markedly. We’ll explore what declining profitability, despite sizable revenue gains, means for...

Chartwell Retirement Residences recently announced a cash distribution of $0.051 per Trust Unit, payable on September 15, 2025, to unitholders of record as of August 29, 2025; it also reported second quarter and half-year 2025 results, showing sales of CA$270.77 million and CA$520.27 million, respectively, along with a net income of CA$27.41 million for the six months ended June 30, 2025. While the company recorded a quarterly net loss, the transition to a significant net profit for the...

Liberty Broadband reported strong earnings for the second quarter ended June 30, 2025, with sales rising to US$261 million and net income increasing to US$383 million from the previous year. Despite not repurchasing any shares in the latest quarter, the company has completed a massive buyback program totaling nearly 34.2% of its outstanding shares since 2016, amounting to over US$8.1 billion. We’ll examine how Liberty Broadband’s significant year-over-year net income growth updates its...

Earlier this month, Oddity Tech Ltd. reported second quarter sales of US$241.14 million and net income of US$49.29 million, also raising its full-year 2025 net revenue guidance to a new range of US$799 million to US$804 million. This upward revision to revenue targets following robust quarterly results highlights the company’s confidence in its operating momentum and future demand outlook. We’ll explore how Oddity Tech’s strengthened full-year guidance, reflecting accelerating business...

Globus Medical reported strong second-quarter 2025 results, with sales of US$745.34 million and net income of US$202.85 million, along with reaffirmed full-year revenue guidance of US$2.80 billion to US$2.90 billion. The company completed a share buyback of 411,000 shares for US$24.99 million, signaling ongoing confidence in its capital allocation strategy. We’ll now explore how Globus Medical’s robust earnings growth and reaffirmed guidance influence its broader investment narrative. We've...

Ascendis Pharma released its second quarter and half-year 2025 financial results, reporting sales of €158.05 million and €259 million, respectively, with both periods showing sharply reduced net losses compared to the previous year. This marked improvement in revenue and narrowing of net loss highlights the company's progress toward greater financial stability and operational efficiency as of June 30, 2025. We'll explore how the substantial year-over-year revenue growth and reduced net loss...

NANO Nuclear Energy Inc. recently announced earnings results for the quarter and nine months ended June 30, 2025, reporting a third-quarter net loss of US$7.59 million and a year-to-date net loss of US$32.02 million, both higher than the prior year. Losses per share also widened from the previous year, suggesting increased operational costs or investments contributing to the deeper losses. We'll examine how the larger net loss shapes NANO Nuclear Energy's investment narrative around future...

CF Industries Holdings released its second-quarter 2025 results, reporting US$1.89 billion in sales, steady ammonia production, and updates on share repurchase activity completed under its ongoing buyback program. Notably, management issued full-year guidance projecting gross ammonia output to reach approximately 10 million tons, highlighting continued focus on production scale and operational efficiency. To understand the potential impact on CF Industries Holdings' investment outlook, we'll...

Harmony Biosciences Holdings recently reported second-quarter 2025 earnings, revealing net income of US$39.78 million versus US$11.59 million a year earlier and reaffirmed its full-year 2025 revenue guidance of US$820 million to US$860 million. This sharp improvement in earnings and maintained revenue outlook highlights the company’s operational momentum and management’s confidence in its ongoing business performance. With Harmony Biosciences delivering much higher profits and upholding its...

Labrador Iron Ore Royalty Corporation recently reported its operating and earnings results for the second quarter and first half of 2025, highlighting unaudited production increases but notable declines in both revenue and net income compared to the previous year. This contrast between higher production and weaker earnings points to the pivotal influence of market conditions such as iron ore pricing or operational costs on the company's financial outcomes. We'll explore how Labrador Iron Ore...

Grindr Inc. recently announced its second quarter 2025 earnings results, reporting sales of US$104.22 million and a net income of US$16.64 million, marking a shift from a net loss for the same period last year. This turnaround to profitability, alongside strong year-over-year revenue growth, reflects the company’s improved operational performance and shifting financial trajectory. Now, we’ll explore how Grindr’s return to profitability could influence its investment narrative and future...

Core Scientific reported its second quarter 2025 earnings on August 8, showing revenue of US$78.63 million compared to US$141.1 million a year earlier, with a net loss of US$936.8 million and basic loss per share from continuing operations of US$0.04. Despite continued year-over-year declines in revenue and net losses, major Wall Street analysts recently upgraded or reaffirmed positive ratings for the company after the earnings report. We’ll examine how improved analyst sentiment, following...

OceanaGold Corporation recently announced strong second-quarter results, reporting sales of US$432.4 million and net income of US$114.1 million, alongside higher gold and copper production, a dividend increase, and completion of its major share buyback program. These developments mark significant operational and financial progress, reflecting enhanced shareholder returns and management changes amid robust production and capital discipline. We'll explore how the company's sharply improved...

Earlier this month, Dynavax Technologies Corporation raised its full-year 2025 revenue guidance for HEPLISAV-B to a range of US$315 million to US$325 million and posted quarterly results showing second-quarter revenue climbed to US$95.44 million, with net income reaching US$18.72 million. The guidance increase reflects strong performance in the first half, while the earnings report highlights significant year-over-year growth in both revenue and profit margins for the company. To understand...

Earlier this month, V2X, Inc. filed for a follow-on equity offering of 2,000,000 shares of common stock shortly after reporting a return to profitability in its second-quarter results and reaffirming its full-year revenue guidance. This sequence of events highlights how the company is taking advantage of renewed financial momentum to strengthen its balance sheet through equity financing. We'll explore how V2X’s follow-on equity offering, coming right after its profitability turnaround, may...

In the past week, Claritev Corporation reported second-quarter results showing higher sales at US$241.57 million and a sharply reduced net loss of US$62.64 million, while updating its full-year 2025 revenue guidance to between flat and 2% growth from 2024 levels. The company’s US$400 million universal shelf registration, covering a range of securities, adds financial flexibility to support potential future initiatives and growth plans. We will explore how Claritev’s improving financial...

On August 6, 2025, Savaria Corporation reported its second-quarter and half-year results, showing sales growth to CA$226.75 million and CA$446.98 million, respectively, along with improved net income and earnings per share compared to the previous year. An important insight from these results is the considerable increase in net income for both periods, reflecting operational improvements and stronger profitability initiatives at the company. We'll examine how Savaria's jump in net income and...

IAMGOLD Corporation recently released its second quarter 2025 results, reporting increased gold production and sales alongside updated full-year production guidance of 735,000 to 820,000 ounces. Despite higher revenues, the company recorded slightly lower net income and earnings per share compared to the previous year. The combination of record gold sales and production growth positions IAMGOLD at a pivotal point as it targets expanded operational output for the remainder of 2025. We’ll...

Vera Therapeutics recently reported a second quarter net loss of US$76.53 million, significantly higher than a year ago, and announced a US$200 million follow-on equity offering of Class A common stock. The concurrent disclosure of increased quarterly losses and a major capital raise highlights potential funding needs and ongoing operational pressures facing the company. We’ll examine how Vera Therapeutics’ expanded capital raise shapes its investment narrative amid growing financial...

HLSE:BITTI 1 Year Share Price vs Fair Value Explore Bittium Oyj's Fair Values from the Community and select yours...